Posterior Myocardial Infarction

Introduction

Posterior myocardial infarction (PMI) is a type of heart attack that affects the back (posterior) wall of the left ventricle. It is often underdiagnosed because the typical ECG leads do not directly record electrical activity from the posterior wall.

Causes

PMI is usually caused by occlusion of the posterior descending artery (PDA), which is most commonly a branch of the right coronary artery (RCA) or, in some cases, the left circumflex artery (LCX).

ECG Diagnosis

Detecting PMI requires careful ECG interpretation: - Signs in standard leads: - ST-segment depression in leads V1-V3 (reciprocal changes) - Prominent R waves in V1-V2 - T wave inversion in V1-V3 - Use of posterior leads (V7-V9): - ST-segment elevation of at least 0.5 mm is considered significant

Symptoms

Like other types of myocardial infarctions, PMI presents with: - Chest pain (which may radiate to the back) - Shortness of breath - Nausea and diaphoresis (sweating)

Treatment

Management is similar to other STEMIs and should follow guideline-directed therapy: 1. Acute Revascularization: - Immediate percutaneous coronary intervention (PCI) is the preferred strategy - If PCI is unavailable, fibrinolytic therapy may be considered 2. Pharmacological Treatment: - Aspirin and P2Y12 inhibitors (e.g., clopidogrel, ticagrelor) - Anticoagulation (e.g., heparin) - Beta-blockers (if no contraindications) - Nitrates (for symptom relief, while monitoring for hypotension) - Statins (high-intensity therapy) 3. Monitoring & Complications: - Risk of cardiogenic shock, arrhythmias, and ventricular dysfunction must be assessed

Conclusion

Posterior MI requires a high index of suspicion for early diagnosis, appropriate ECG recognition, and rapid treatment with reperfusion therapy to improve outcomes.

Source recommendations

1. American Heart Association (AHA) STEMI Guidelines

  1. https://www.heart.org/en/professional/quality-improvement/mission-lifeline/mission-lifeline-hospital-stemi-and-nstemi-recognition
  2. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309
  3. https://www.heart.org/en/professional/quality-improvement/mission-lifeline
  4. https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/algorithms
  5. https://professional.heart.org/en/science-news/2025-guideline-for-the-management-of-patients-with-acute-coronary-syndromes

2. European Society of Cardiology (ESC) Guidelines for Myocardial Infarction

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-Guidelines
  2. https://academic.oup.com/eurheartj/article/44/38/3720/7243210
  3. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Fourth-Universal-Definition-of-Myocardial-Infarction
  4. https://academic.oup.com/eurheartj/article/39/2/119/4095042
  5. https://pubmed.ncbi.nlm.nih.gov/28886621/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow